Pfizer standalone net profit rises 37.96% in the March 2024 quarter

Sales decline 4.54% to Rs 546.63 crore

Net profit of Pfizer rose 37.96% to Rs 178.86 crore in the quarter ended March 2024 as against Rs 129.65 crore during the previous quarter ended March 2023. Sales declined 4.54% to Rs 546.63 crore in the quarter ended March 2024 as against Rs 572.64 crore during the previous quarter ended March 2023.

For the full year,net profit declined 11.64% to Rs 551.33 crore in the year ended March 2024 as against Rs 623.93 crore during the previous year ended March 2023. Sales declined 9.55% to Rs 2193.17 crore in the year ended March 2024 as against Rs 2424.76 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear EndedMar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.Sales546.63572.64 -5 2193.172424.76 -10 OPM %34.6531.76 -28.9733.36 - PBDT257.61210.72 22 800.40896.52 -11 PBT243.86184.31 32 738.12791.01 -7 NP178.86129.65 38 551.33623.93 -12

Powered by Capital Market - Live News